The pharmaceutical company Novartis has announced that the schizophrenia drug Fanapt (iloperidone) is now available to adult patients.
Fanapt is an oral antipsychotic that is designed to be taken twice a day. It received FDA approval in May 2009.
Short-term clinical trials showed that taking the drug resulted in a significant improvement in symptoms, compared to patients on a placebo. The most common side effects were dry mouth, dizziness, fatigue, nasal congestion, drowsiness, rapid heart rate, and weight gain.
The effectiveness of taking Fanapt beyond 6 weeks has not yet been studied, so your doctor will need to monitor you closely if he or she has you continue the treatment past that point.
Comments
Comments are closed for this post.
